Cite
Adjuvant treatment for melanoma in clinical practice - Trial versus reality
MLA
Meza, Melissa M.de, et al. “Adjuvant Treatment for Melanoma in Clinical Practice - Trial versus Reality.” European Journal of Cancer, 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312603083&authtype=sso&custid=ns315887.
APA
Meza, M. M. de, Ismail, R. K., Rauwerdink, D., Not, O. J. van, Breeschoten, J. van, Blokx, W. A. M., Bonenkamp, H., Boers-Sonderen, M. J., Suijkerbuijk, K. P. M., & Wouters, M. W. J. M. (2021). Adjuvant treatment for melanoma in clinical practice - Trial versus reality. European Journal of Cancer.
Chicago
Meza, Melissa M. de, Rawa K. Ismail, Daan Rauwerdink, Olivier J. van Not, Jesper van Breeschoten, Willeke A.M. Blokx, H. Bonenkamp, M.J. Boers-Sonderen, Karijn P.M. Suijkerbuijk, and Michel W.J.M. Wouters. 2021. “Adjuvant Treatment for Melanoma in Clinical Practice - Trial versus Reality.” European Journal of Cancer. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312603083&authtype=sso&custid=ns315887.